ZOVIRAX Drug Patent Profile
✉ Email this page to a colleague
When do Zovirax patents expire, and when can generic versions of Zovirax launch?
Zovirax is a drug marketed by Mylan, Bausch, and Glaxosmithkline. and is included in six NDAs.
The generic ingredient in ZOVIRAX is acyclovir sodium. There are fifty-six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the acyclovir sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zovirax
A generic version of ZOVIRAX was approved as acyclovir sodium by FRESENIUS KABI USA on May 13th, 1998.
Summary for ZOVIRAX
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 6 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 185 |
Clinical Trials: | 12 |
Patent Applications: | 3,758 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ZOVIRAX |
What excipients (inactive ingredients) are in ZOVIRAX? | ZOVIRAX excipients list |
DailyMed Link: | ZOVIRAX at DailyMed |
US Patents and Regulatory Information for ZOVIRAX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan | ZOVIRAX | acyclovir | CAPSULE;ORAL | 018828-001 | Jan 25, 1985 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mylan | ZOVIRAX | acyclovir | SUSPENSION;ORAL | 019909-001 | Dec 22, 1989 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glaxosmithkline | ZOVIRAX | acyclovir sodium | INJECTABLE;INJECTION | 018603-003 | Aug 30, 1983 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ZOVIRAX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Mylan | ZOVIRAX | acyclovir | CAPSULE;ORAL | 018828-001 | Jan 25, 1985 | ⤷ Try a Trial | ⤷ Try a Trial |
Mylan | ZOVIRAX | acyclovir | TABLET;ORAL | 020089-002 | Apr 30, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
Bausch | ZOVIRAX | acyclovir | CREAM;TOPICAL | 021478-001 | Dec 30, 2002 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ZOVIRAX
See the table below for patents covering ZOVIRAX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Finland | 752465 | ⤷ Try a Trial | |
Hong Kong | 95485 | TOPICAL FORMULATIONS OF 9-(2-HYDROXYETHOXYMETHYL)GUANINE | ⤷ Try a Trial |
Austria | A676375 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ZOVIRAX
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0809498 | SPC/GB10/012 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112 |
0809498 | 10C0038 | France | ⤷ Try a Trial | PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |